View in EDS HTML Full Text PDF Full Text

C-Peptide and BMi predict anti-hyperglycemic treatment lines in breast cancer patients treated with Alpelisib.

Saved in:
Bibliographic Details
Title: C-Peptide and BMi predict anti-hyperglycemic treatment lines in breast cancer patients treated with Alpelisib.
Authors: Carrillo-Lopez E; Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa. Universidad Autónoma de Madrid, 28006, Madrid, Spain., Sebastian-Valles F; Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa. Universidad Autónoma de Madrid, 28006, Madrid, Spain. fernando.sebastian@estudiante.uam.es.; Department of Oncology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa, 28006, Madrid, Spain. fernando.sebastian@estudiante.uam.es., Sager La Ganga C; Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa. Universidad Autónoma de Madrid, 28006, Madrid, Spain., Ballesteros A; Department of Oncology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa, 28006, Madrid, Spain., Navas-Moreno V; Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa. Universidad Autónoma de Madrid, 28006, Madrid, Spain., Bañón D; Department of Oncology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa, 28006, Madrid, Spain., López Martí MP; Department of Oncology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa, 28006, Madrid, Spain., Marazuela M; Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa. Universidad Autónoma de Madrid, 28006, Madrid, Spain., Arranz Martín JA; Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa. Universidad Autónoma de Madrid, 28006, Madrid, Spain.
Source: Endocrine [Endocrine] 2024 Nov; Vol. 86 (2), pp. 470-477. Date of Electronic Publication: 2024 Jul 04.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9434444 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0100 (Electronic) Linking ISSN: 1355008X NLM ISO Abbreviation: Endocrine Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38963515
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: C-Peptide and BMi predict anti-hyperglycemic treatment lines in breast cancer patients treated with Alpelisib.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Carrillo-Lopez+E%22">Carrillo-Lopez E</searchLink>; Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa. Universidad Autónoma de Madrid, 28006, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sebastian-Valles+F%22">Sebastian-Valles F</searchLink>; Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa. Universidad Autónoma de Madrid, 28006, Madrid, Spain. fernando.sebastian@estudiante.uam.es.; Department of Oncology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa, 28006, Madrid, Spain. fernando.sebastian@estudiante.uam.es.<br /><searchLink fieldCode="AU" term="%22Sager+La+Ganga+C%22">Sager La Ganga C</searchLink>; Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa. Universidad Autónoma de Madrid, 28006, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ballesteros+A%22">Ballesteros A</searchLink>; Department of Oncology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa, 28006, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Navas-Moreno+V%22">Navas-Moreno V</searchLink>; Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa. Universidad Autónoma de Madrid, 28006, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bañón+D%22">Bañón D</searchLink>; Department of Oncology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa, 28006, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22López+Martí+MP%22">López Martí MP</searchLink>; Department of Oncology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa, 28006, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Marazuela+M%22">Marazuela M</searchLink>; Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa. Universidad Autónoma de Madrid, 28006, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Arranz+Martín+JA%22">Arranz Martín JA</searchLink>; Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa. Universidad Autónoma de Madrid, 28006, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229434444%22">Endocrine</searchLink> [Endocrine] 2024 Nov; Vol. 86 (2), pp. 470-477. <i>Date of Electronic Publication: </i>2024 Jul 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9434444 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-0100 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221355008X%22">1355008X </searchLink><i>NLM ISO Abbreviation: </i>Endocrine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38963515
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12020-024-03924-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 470
    Titles:
      – TitleFull: C-Peptide and BMi predict anti-hyperglycemic treatment lines in breast cancer patients treated with Alpelisib.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Carrillo-Lopez E
      – PersonEntity:
          Name:
            NameFull: Sebastian-Valles F
      – PersonEntity:
          Name:
            NameFull: Sager La Ganga C
      – PersonEntity:
          Name:
            NameFull: Ballesteros A
      – PersonEntity:
          Name:
            NameFull: Navas-Moreno V
      – PersonEntity:
          Name:
            NameFull: Bañón D
      – PersonEntity:
          Name:
            NameFull: López Martí MP
      – PersonEntity:
          Name:
            NameFull: Marazuela M
      – PersonEntity:
          Name:
            NameFull: Arranz Martín JA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2024 Nov
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1559-0100
          Numbering:
            – Type: volume
              Value: 86
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Endocrine
              Type: main
ResultId 1